Abstract
Long-term sequelae of severe acute respiratory coronavirus-2 (SARS-CoV-2) infection may include increased incidence of diabetes. Here we describe the temporal relationship between new type 2 diabetes and SARS-CoV-2 infection in a nationwide database. We found that while the proportion of newly diagnosed type 2 diabetes increased during the acute period of SARS-CoV-2 infection, the mean proportion of new diabetes cases in the 6 months post-infection was about 83% lower than the 6 months preinfection. These results underscore the need for further investigation to understand the timing of new diabetes after COVID-19, etiology, screening, and treatment strategies.
Original language | English (US) |
---|---|
Article number | e90 |
Journal | Journal of Clinical and Translational Science |
Volume | 7 |
Issue number | 1 |
DOIs | |
State | Published - Mar 8 2023 |
Bibliographical note
Publisher Copyright:© The Author(s), 2023. Published by Cambridge University Press on behalf of The Association for Clinical and Translational Science.
Keywords
- COVID-19
- PASC
- epidemiology
- new diabetes
- type 2 diabetes
PubMed: MeSH publication types
- Journal Article